<?xml version="1.0" encoding="UTF-8"?>
<ref id="B44-viruses-11-00322">
 <label>44.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>García-Arriaza</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Cepeda</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Hallengärd</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Sorzano</surname>
    <given-names>C.Ó.S.</given-names>
   </name>
   <name>
    <surname>Kümmerer</surname>
    <given-names>B.M.</given-names>
   </name>
   <name>
    <surname>Liljeström</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Esteban</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection</article-title>
  <source>J. Virol.</source>
  <year>2014</year>
  <volume>88</volume>
  <fpage>3527</fpage>
  <lpage>3547</lpage>
  <pub-id pub-id-type="doi">10.1128/JVI.03418-13</pub-id>
  <pub-id pub-id-type="pmid">24403588</pub-id>
 </element-citation>
</ref>
